This panel includes hormones that have been implicated in gynecomastia by several studies. Gynecomastia is a benign enlargement of the male breast resulting from a growth of the glandular tissue of the breast. Since it causes anxiety, psychosocial discomfort and fear of breast cancer, early diagnostic evaluation is important, and patients usually seek medical attention. Causes include hormone imbalance and genetic predisposition.

This PCT after cycle panel is designed to measure the health and recovery of the Hypothalamic-Pituitary-Testicular Axis (HPTA) after attempting to normalize it spontaneously or with the use of Post-Cycle Therapy (PCT) . PCT is prescribed by some physicians for men who stop testosterone replacement therapy (TRT) or other androgens. Fasting is required for CMP (glucose test).

This affordable male hormone panel includes the most accurate assays used as gold standard for measuring:

1. Total Testosterone (Liquid chromatography/MS-MS) 
2.  Free Testosterone (Equilibrium Ultrafiltration)
3.  Sex Hormone-Binding Globulin (SHBG)
4.  Estradiol, Ultra Sensitive (LC/MS-MS) 
5.  DHT level  (LC/MS) 
6.  Prolactin
7.  Dehydroepiandrosterone sulphate (DHEA-S)